Conference Information
Sign of The Times (LSACJ 2021)

Sign of The Times (LSACJ 2021) is the new form of LSACJ annual conference. We are conducting on-line meetings, due to the COVID-19 pandemic.
Topics

  • Joint Meetings
  • Literature commentaries
  • Young Researcher Presentations
  • Highlighted Research
  • Co-Chairs
    Dan Ohtan WANG, Ph.D.
    Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University
    Program-Specific Research Center Associate Professor / PI

    Research Interests

    Neuroscience, Chemical biology

    Our group studies the molecular and cell biological mechanisms of learning-related neuronal plasticity, a process in which the strength and the number of synaptic connections in our brain are altered by experience. Such structural and functional changes occur in an activity-dependent manner and are mediated by highly orchestrated gene networks. Our goal is to gain fundamental understanding of the regulation of gene expression within the neural circuits during long-term neuronal plasticity, with an emphasis on the spatiotemporal regulation mechanisms. In an essential effort to achieve this goal, we are developing effective RNA live-imaging methods for sensitive and quantitative imaging of RNA dynamics in living neural circuits. Our research has a strong orientation to incorporate novel bioactive materials and chemical approaches to study gene regulation and neuron function, which drives us to do cross-disciplinary collaboration research inside and outside our institute.


    Biao MA, Ph.D.
    Foundation for Biomedical Research and Innovation at Kobe (FBRI)
    Senior Researcher

    Research Interests

    Computational chemistry, Molecular modeling, In silico drug discovery

    In the pharmaceutical industry, developing new drugs efficiently while keeping development costs down has been one of the important challenges, and there are great expectations for in silico drug discovery using computers. In particular, the world fastest class supercomputer "K computer" can be used, and computational science and information science in the field of drug discovery is about to enter its flowering season. We are working on the research and development of the world's most advanced supercomputer based drug discovery technology with the aim of forming an in silico drug discovery base in the Kobe Biomedical Innovation Cluster (KBIC) by utilizing the location close to the “K computer”.

    Scientific Program Committee

    Li SUN

    Kindai Univ.

    Tsuyoshi DAI

    Hyogo University of Health Sciences

    Jiangji JIANG

    Kyoto Univ.

    Jiuyang CHANG

    NA

    Zixuan WANG

    Tokyo Univ.

    Yi Zhou

    Osaka Univ.

    Yu-Shi TIAN

    Osaka Univ.

    Organizing Committee

    LSACJ